Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database

Objective Adult growth hormone deficiency (AGHD) is an underdiagnosed disease associated with increased morbidity and mortality. Identifying people who may benefit from growth hormone (GH) therapy can be challenging, as many AGHD symptoms resemble those of aging. We developed an algorithm to potentially help providers stratify people by their likelihood of having AGHD. Design The algorithm was developed with, and applied to, data in the anonymized Truven Health MarketScan® claims database. Patients. A total of 135 million adults in the US aged ≥18 years with ≥6 months of data in the Truven database. Measurements. Proportion of people with high, moderate, or low likelihood of having AGHD, and differences in demographic and clinical characteristics among these groups. Results Overall, 0.5%, 6.0%, and 93.6% of people were categorized into groups with high, moderate, or low likelihood of having AGHD, respectively. The proportions of females were 59.3%, 71.6%, and 50.4%, respectively. People in the high- and moderate-likelihood groups tended to be older than those in the low-likelihood group, with 58.3%, 49.0%, and 37.6% aged >50 years, respectively. Only 2.2% of people in the high-likelihood group received GH therapy as adults. The high-likelihood group had a higher incidence of comorbidities than the low-likelihood group, notably malignant neoplastic disease (standardized difference −0.42), malignant breast tumor (−0.27), hyperlipidemia (−0.26), hypertensive disorder (−0.25), osteoarthritis (−0.23), and heart disease (−0.22). Conclusions This algorithm may represent a cost-effective approach to improve AGHD detection rates by identifying appropriate patients for further diagnostic testing and potential GH replacement treatment.

[1]  I. Dimopoulou,et al.  Covid-19 and Growth Hormone/Insulin-Like Growth Factor 1: Study in Critically and Non-Critically Ill Patients , 2021, Frontiers in Endocrinology.

[2]  A. Hamdy,et al.  A Suggested Role of Human Growth Hormone in Control of the COVID-19 Pandemic , 2020, Frontiers in Endocrinology.

[3]  Navid Nedjatian,et al.  Country-specific differences in adult growth hormone deficiency diagnosis and treatment rates , 2020 .

[4]  S. Larsson,et al.  Is Type 2 Diabetes Causally Associated With Cancer Risk? Evidence From a Two-Sample Mendelian Randomization Study , 2020, Diabetes.

[5]  S. Radovick,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE. , 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[6]  I. Shimon,et al.  Adult growth hormone deficiency in CEE region: Heterogeneity of the patient pathway. , 2019, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[7]  A. Juul,et al.  THERAPY OF ENDOCRINE DISEASE: Growth hormone replacement therapy in adults: 30 years of personal clinical experience. , 2018, European journal of endocrinology.

[8]  Shin-Hye Kim,et al.  Effects of growth hormone on glucose metabolism and insulin resistance in human , 2017, Annals of pediatric endocrinology & metabolism.

[9]  C. Benbassat,et al.  CENTRAL DIABETES INSIPIDUS: CLINICAL CHARACTERISTICS AND LONG-TERM COURSE IN A LARGE COHORT OF ADULTS. , 2017, Endocrine Practice.

[10]  M. Murad,et al.  Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[11]  K. Straif,et al.  Body Fatness and Cancer--Viewpoint of the IARC Working Group. , 2016, The New England journal of medicine.

[12]  M. Neary,et al.  Incidence and prevalence of acromegaly in a large US health plan database , 2016, Pituitary.

[13]  G. Tirabassi,et al.  Impact of adult growth hormone deficiency on metabolic profile and cardiovascular risk [Review]. , 2015, Endocrine journal.

[14]  J. Ioannidis,et al.  Authors’ reply to editorial linked to their umbrella review of meta-analyses of observational studies on type 2 diabetes and cancer , 2015, BMJ : British Medical Journal.

[15]  Joseph M Pappachan,et al.  Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies. , 2015, The Journal of clinical endocrinology and metabolism.

[16]  D. Dunger,et al.  GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults , 2015, European journal of endocrinology.

[17]  J. Ioannidis,et al.  Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies , 2015, BMJ : British Medical Journal.

[18]  G. Merriam,et al.  Adult Growth Hormone Deficiency – Benefits, Side Effects, and Risks of Growth Hormone Replacement , 2013, Front. Endocrinol..

[19]  M. Thunander,et al.  Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. , 2013, European journal of endocrinology.

[20]  M. Zwahlen,et al.  Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. , 2011, The Journal of clinical endocrinology and metabolism.

[21]  K. Basen-Engquist,et al.  Obesity and Cancer Risk: Recent Review and Evidence , 2011, Current oncology reports.

[22]  D. Christiani,et al.  Body mass index is associated with the development of acute respiratory distress syndrome , 2009, Thorax.

[23]  Peter C. Austin,et al.  Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research , 2009, Commun. Stat. Simul. Comput..

[24]  P. Chanson,et al.  Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults , 2008, Journal of endocrinological investigation.

[25]  M. Frydenberg,et al.  Morbidity and GH deficiency: a nationwide study. , 2007, European journal of endocrinology.

[26]  M. Frydenberg,et al.  Incidence of GH deficiency - a nationwide study. , 2006, European journal of endocrinology.

[27]  M. Vance,et al.  Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[28]  F. Manzano,et al.  Incidence of acute respiratory distress syndrome and its relation to age. , 2005, Journal of critical care.

[29]  Matthias Egger,et al.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.

[30]  Brenda J. Crowe,et al.  Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? , 2002, The Journal of clinical endocrinology and metabolism.

[31]  R. García-mayor,et al.  Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain , 2001, Clinical endocrinology.

[32]  A. Lucas,et al.  Diagnostic efficiency of serum IGF-I, IGF-binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and urinary GH measurements in the diagnosis of adult GH deficiency: importance of an appropriate reference population. , 2000, European journal of endocrinology.

[33]  G. Sassolas,et al.  GH deficiency in adults: an epidemiological approach. , 1999, European journal of endocrinology.

[34]  R. Couch,et al.  Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989. , 1991, American journal of epidemiology.

[35]  G. Merriam,et al.  Hypertension in Growth Hormone Excess and Deficiency , 2013 .

[36]  C. Mantzoros,et al.  IGF1 and IGFBP3 in acute respiratory distress syndrome. , 2012, European journal of endocrinology.

[37]  V. Montori,et al.  Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis. , 2012, European journal of endocrinology.

[38]  A. Colao,et al.  The role for growth hormone in linking arthritis, osteoporosis, and body composition. , 2007, Journal of Endocrinological Investigation.

[39]  K. Ho,et al.  Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II : a statement of the GH Research Society in association with the European Society for Pediatric , 2007 .

[40]  U. Feldt-Rasmussen,et al.  Adult Growth Hormone Deficiency Clinical Management , 2000 .

[41]  P. Sönksen,et al.  Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. , 1990, Hormone research.